Topic:

Emerging Markets

Latest Headlines

Latest Headlines

Mylan, Ranbaxy, others to bring cheap Sovaldi to 91 markets

Cheap Sovaldi is on the way, and it could very well be coming to an emerging market near you. Gilead has ironed out a licensing deal for the hep C wonder with 7 companies--including Mylan and Ranbaxy--and they'll bring low-cost copies to 91 developing countries.

Abbott invests $60M in optics--its fastest growing device segment--with Malaysian plant

Abbott Laboratories will invest $60 million in an intraocular lens manufacturing plant in Malaysia. The plant is expected to employ about 500 people and to be operational next year, producing 1 million sets of IOLs a year.

Blackberry to integrate medical devices in India

Blackberry is launching an ambitious project to integrate thousands of medical devices in India in order to detect illnesses earlier. 

Gilead to offer cheap Sovaldi to 80 countries

Turns out it's not just India and Egypt that will be getting price breaks on Gilead's hep C star, Sovaldi. The drugmaker is close to reaching an agreement with generics makers to bring low-cost versions of the $84,000 wonder drug to about 80 developing countries, according to EVP Gregg Alton.

Sweden's Recipharm moves on Italy with $160M deal for Corvette

Sweden's Recipharm in April issued additional shares, preparing itself for expansion. Now the midsized contract and development group is putting those plans into play, buying an Italian company for more than $160 million, getting new business in Italy and emerging markets, as well as new capabilities.

China's top health authority calls for more homegrown med tech

Global med tech companies could soon face mounting competition in China, as the country's top health authority is calling for a new set of initiatives to promote homegrown products and jumpstart the domestic industry.

Brazil fines Merck KGaA $1.8M for alleged generics conspiracy

Conspiring to keep distributors from working with generic drugmakers is a no-no in Brazil, and the country's antitrust regulator is fining Merck KGaA for allegedly doing just that. And while the move harkens back to a meeting that happened 5 years ago, it's reflective of actions taken more recently by regulators in the U.S. and EU.

Baxter to add recombinant protein processing suite at Singapore plant

In the 11 years since the Singapore government created a biologics CMO to kickstart the local sector, a who's who of biopharma manufacturers have opened plants in the country. Baxter is among the latest to set up shop in Singapore and is already pushing ahead with expansion plans.

UPDATED: GSK's private eye sentenced to 2.5 years in Chinese prison

China finally has a verdict on the husband-wife investigator team linked to GlaxoSmithKline's bribery scandal: U.K. citizen Peter Humphrey is headed for 2.5 years behind bars, and his American wife, Yu Yingzeng, will get 2 years, Pharmafile reports.

GE-funded NGO aims to repair developed-world medical devices in the developing world

General Electric's $2 billion commitment to invest in Africa includes the launch of a program to train biomedical engineering technicians in Nigeria, where patients are dying of treatable conditions because the devices to treat them are left unfixed due to a lack of know-how, according to a prominent nongovernmental organization.